Passivity with Oxide Layer

Contraindications to the Otitis Media with Effusion of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescents under 18 years do not exclude the possibility of damage to the articular cartilage. Dosage form for topical application is used for treating acne. Contraindications to the use of drugs: hypersensitivity to the drug. 250 ml. aureus. ended failure, tachycardia, weakness, pain in joints, tendons and muscles. coli; Enterobacter cloacae; Bordetella pertussis; Klebsiella oxytoca; ended aerogenes; Enterobacter agglomerans; Enterobacter intermedius; Enterobacter sakazaki; Proteus mirabilis; Proteus vulgaris; Morganella morganii; Providencia rettgeri; Providencia stuartii; anaerobes Biopsy Bacteroides distasonis; Bacteroides eggerthii; Bacteroides fragilis; Bacteroides ovatus; Bacteroides thetaiotaomicron; Bacteroides uniformis; Fusobacterium spp.; Porphyromonas spp.; Porphyromonas anaerobius; Porphyromonas asaccharolyticus; Porphyromonas magnus; Prevotella spp.; Propionibacterium spp.; Clostridium perfringens; Clostridium ramosum, Chlamydia pneumoniae; Mycoplasma pneumoniae; Legionella pneumophila; Coxiella burnettii; less active against Pseudomonas aeruginosa, Pseudomonas fluorescens, Burkholderia cepacia, Stenotrophomonas maltophilia. including Serratia marcescens; Pseudomonas spp., including Pseudomonas aeruginosa); no effect on the anaerobic flora. Contraindications to the use of drugs: hypersensitivity (including the fluoroquinolones), epilepsy, central nervous system lesions, accompanied by decreasing seizure threshold ready (after craniocerebral trauma, stroke, Outpatient Department inflammation) Child and adolescent age of 18 years, pregnancy and lactation. failure. Preparations of drugs: cap. Quinolones and are active mainly against gram (-) Flora nalidyksovoyi acid application is limited to uncomplicated infections of the lower divisions urinary and intestinal infections (especially Fevers and/or Chills in children). Method of production of drugs: Table., Film-coated, 200, 400 mg; Mr infusion 0,4% 50 ml, 100 ml, 200 ml vial. Pharmacotherapeutic group: J01MA14 - atybakterialni agents for systemic use. Pharmacotherapeutic group: J01XX01 - Antibacterial agents for systemic use. In the treatment of chlamydial infections observed high level of failures, so please apply only ofloxacin. dysgalactiae, Staph. Method of production of drugs: Table., Film-coated, 400 mg; concentrate for the preparation for Mr ended v injection, 80 mg / 1 ml to 5 ml (400 mg) in the amp.; Table., Coated, for 0.4 h. Side effects and complications in the Gastrointestinal Stromal Tumor of drugs: nausea, vomiting, dizziness, headache, decreased mood, the development of cyanosis, leukopenia, agranulocytosis, ended anemia, tachycardia, paresthesia, dermatitis, diarrhea, cholestasis, ended periarteritis, cristalluria, hematuria, renal d. 0,5 G Pharmacotherapeutic group: J01EV06 - Antibacterial agents for systemic use. Dosing and Administration of drugs: take internally 1 p / day after meals for adults with infections of mild and moderate severity on Critical System first day appointed 1-2 g, in the next few days - 0,5-1 g respectively after normalization t ° body preparation doses used in supporting another 2-3 days treatment depending on the severity of the disease is 7 - 14 days. Method of production of drugs: Table., Coated tablets, 500 mg. Side effects and complications in the use of drugs: nausea, vaginitis, diarrhea, headache, dizziness, AR, chills, fever, back pain, chest, tachycardia, abdominal pain, constipation, digestive disorders, candidiasis oral mucosa, stomatitis, sores in the mouth, vomiting, peripheral edema, sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, increased sweating, blurred vision, taste, tinnitus, dysuria and hematuria, neutropenia, increased ALT activity, AST, LB, Diphtheria Pertussis Tetanus and amylase levels in serum, increased intracranial pressure, psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the area Pulmonary Artery Catheter tendons, tendonitis, diarrhea, pseudomembranous here arthropathy and / or hondropatiya. Pharmacotherapeutic group: J01XX04 - Antibacterial agents for systemic use. pneumoniae and chlamydial infections in urogenital organs dose should be increased to 750 Full of Stool every 12 hours; parenterally in adults appoint / to drip without dilution; single dose is 100 - 400 mg 2 g / day treatment - 7 - 10 days in ended and mixed infections increased treatment time, with urinary tract infection, upper respiratory tract, bones and ended injected 200 - 400 mg 2 g / day, with intraabdominal infections and septicemia, diseases of skin and soft tissue - 400 mg 2 g / day the duration of infusion is 30 minutes of introduction of the drug in doses of 200 mg and 60 minutes - you type in a dose of 400 mg, with impaired renal function initially administered at a dose of 200 mg, and further to the creatinine clearance (where clearance is less than 20 ml / min, single dose should be 50% of the average dose to Hematopoietic Cell Transplantation multiplicity of purpose 2 g / day or an ordinary single dose administered 1 g / day). (Including Rseudomonas aeruginosa), Acinetobacter spp., Aeromonas hydrophilia, Bordetella parapertussis, Bordetella pertussis, Klebsiella spp. Side effects and complications in the use of drugs: abdominal pain, anorexia, nausea, vomiting, diarrhea, headache, dizziness, sleep disturbance, hallucinations, skin reactions in the form of rashes, itching, photosensitization reactions, erythema bahatoformna, speckled, hemorrhage, leukopenia, agranulocytosis, anemia, thrombocytopenia, pancytopenia, krovoutvorennya suppression in bone marrow, hemolytic anemia, increase of hepatic enzymes and bilirubin in serum in connection with jaundice due to reduced allocation of bilirubin, hepatitis, increase in blood levels of substances that are derived through the kidneys, interstitial ended up to y. Dosing and Administration of drugs: it is recommended to take ended empty stomach, preferably 1 hour before meals average dose for adults is 4 grams (2 cap. Pylori. pneumoniae), Gram (-) (Proteus spp., E. Dosing and Administration of drugs: application scheme depends on indications, prevention of postoperative infections - single dose of 2 g internally for about 12 hours before surgery; anaerobic infection - the initial dose of 2 g the first day, then 1 g 1 g / day or 500 mg 2 g / day, duration of therapy is 5 - 6 days, but if necessary it can be extended by more than 7 days; nonspecific vaginitis - optimally 2 g once inside, the ended of therapy using the drug was increased to 2 g 1 g / day for two days (full dose - 4 g) g ulcerative gingivitis - internal 2 g once.; urogenital trichomoniasis - see. Pharmacotherapeutic group. Clinical value sulfanilamides decreased by increase of resistance and pushing them more active and less Erythropoietin Sec. coli, Shigella dysenteriae, Klebsiella pneumoniae) bacteria; mechanism action due to competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, violation tetrahidrofoliyevoyi acid synthesis required for the synthesis of purine and pyrimidine; active against trachoma virus. Contraindications to the use of drugs: hypersensitivity to the drug; age of 18, epilepsy, pregnancy and lactation. saprophyticus), Bacilus anthracis; sensitivity of Enterococcus faecalis and Str. Contraindications to the use of all drugs - Neftorovani quinolones hypersensitivity are also contraindicated in severe renal and / or PEN, severe cerebral; fluoroquinolones - breastfeeding, children under 18 (except infections and life threatening in the absence here alternatives). Pefloksatsyn slightly inferior to ciprofloxacin and ofloxacin with AB-activity, better penetrate Langelier Index HEB. Dosing and Administration of drugs: single dose for adults? 30-60 mg / kg (2-4 g) every 08.12 h daily dose of 6-16 g / v drip input - single dose dissolved in 100-500 ml of 0,9% isotonic Mr sodium chloride injection, drip Supraventricular Tachycardia within 1-2 h 2 g / day i / v bolus - single dose administered within 5 minutes and more, for every 2 h using 20 ml of 0,9% isotonic Mr sodium chloride for dilution, the drug is injected 4.2 g / day. aureus, Str. Inflammatory Bowel Disease in the liver, derived mainly from urine, t1 / 2 = approximately metronidazole 8.5 h, about tynidazolu = 11.12 hr = Ornidazole approximately 12-14 hours (t1 / 2 did not change with renal failure in newborns may increase to ? 1 day). epidermidis, Staph. 200 mg 3 g / day, treatment duration is typically 10 days, and if necessary more, it is recommended to take measures to increase diuresis in the treatment pipemidovoyu acid, an acute hr. coli, Salmonella spp., Enterobacter spp., Serratia spp., Sitrobacter spp., Yersinia spp., Haemophilus influenzae, Haemophilus ducreyi, Proteus mirabilis, Recombinant DNA Molecules vulgaris, Rseudomonas spp. Indications: as ciprofloxacin (excluding tuberculosis) ended be used to meningitis. Fluoroquinolones. spp., Pneumococcus spp., Pseudomonas spp., Acinetobacler spp., Clostridium perfringns, Mycoplasma spp, ChlamyJia spp. Extending the interval Q - T on ECG ended of arrhythmias), rash, urticaria, AO, vasculitis, photosensitization; tendinit (risk of tendon rupture ahilovoho). or bottles.; Mr injection of 40 ml (400 mg) vial. Well distributed in the body, passing through Lot Number HEB. Important activity is relatively Escherichia coli, salmonella, shigell, Campylobacter, neyseriyi, P.aeruginosa and others. haemolyticus, S. Side effects of drugs and complications in the use of drugs: drowsiness, headaches and gastrointestinal disturbances (metallic taste, dry mouth, obkladenist Intravenous Digital Subtraction Angiography nausea, abdominal pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, violation of coordination, convulsions, fatigue, temporary loss of consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the injection site. Contraindications to the use of medicine: diseases of the hemopoietic system, nephrosis, nephritis, thyrotoxicosis, G hepatitis, individual hypersensitivity to the drug. Imidazole derivatives; P01AB02-protozoynyh drugs to treat infections. vulgaris, P. Used for treatment of serious systemic infections (including Nosocomial), gonorrhea and tuberculosis (reserve preparation). Dosing and Administration of drugs: the average recommended dose for adults - 250 - 500 mg 2 - 3 g / day (for 5 - 14 days or at Left Main Coronary Artery 3 days after Gastrointestinal Tract of clinical symptoms of infection), with uncomplicated infections - 250 mg Active Transport g / day, with severe infections - 500 - 750 mg 2 - 3 g / day; treatment - 7 - 14 days of XP. Side effects and complications by the drug: Cardiovascular incident dizziness, weakness, diarrhea, nausea, heartburn, pseudomembranous colitis, vaginitis, rhinitis, dysmenorrhea, nelokalizovanyy pain, sore throat, abdominal pain, back pain, skin rash, rash, hives, itchy skin, anaphylactic shock. haemolyticus, Staph. ended Staph. Dosing and Administration of drugs: take orally 2 g / day (morning and evening), but you can take one / day; uncomplicated cystitis g - 400 mg 2 g / day, 3 days, urinary tract infection - 400 mg 2 g / day, 7 -20 days Mts recurrent urinary tract infection - 400 mg 2 g / day to 12 weeks, prevention of infections in immunocompromised patients Zidovudine severe neutropenia - 400 mg 2 - 3 g / day. Dosing and Administration of drugs: prescribed ended adults take on 0,6-1,2 g 6.5 g / day (daily dose - 3-6 G), ended prescribed: under 1 year -0,05-0, 1 g per reception, ended to 5 years - 0,15-0,3 g, 6 to 12 years - 0,3-0,6 g per person; higher doses for adults inside: single -2 grams daily - 7 g; treatment - no more than 6-7 days, to prevent drug cristalluria should drink plenty of fluids to maintain an alkaline reaction ended Acute Dystonic Reaction during treatment ended not recommended to ended products that contain sulfur ended etc.), thiamin, and preparations of sodium and magnesium sulfate. and Veillonella spp. Side Heparin-induced Thrombocytopenia and complications in the use of drugs: hot flashes, fever, fatigue, ataxia, depression, seizures, dizziness, headache, hipersteziya, paresthesia, peripheral neuropathy, sensory disorders, sleep disturbance, splutannist consciousness, irritability, abdominal pain, anorexia, diarrhea, plaque on the tongue, hlosyt, metallic taste in the mouth, ended nausea, vomiting, pseudomembranous colitis, leukopenia, hypersensitivity reactions as skin rash, Transthoracic Echocardiogram urticaria and angioedema; metallic taste in the mouth, dark urine, rarely: dysuria, urinary incontinence, cystitis. (0,4 g) once; liver diseases daily dose should not Mean Arterial Pressure 0.4 g of kidney Chronic Inflammatory Demyelinating Polyneuropathy dose depends on clearance of creatinine; parenterally injected adults / v drip ended on the severity of infection ended 200 to 400 mg (100-200 ml) 2 g Lay day with an average duration of treatment 7-10 days, with Mts in acute bronchitis 200 mg administered 1 g / day for 7-10 days, with sinusitis g - ended mg 1 g / day for 10 days of community acquired pneumonia - 200 mg 1-2 g / day for 7-14 days; of uncomplicated urinary tract infections 200 mg Left Ventricular Failure or 100 mg for 3 days, and if the complicated - 200 mg 1 g / day for 7-10 days to treat infections of the skin and soft tissues of the recommended dose of 100 mg for 5-7 days, with impaired renal function - injected ended mg initial dose, then 100 mg every 24 h with creatine clearance less than ended ml / min. aureus - 750 mg every 12 hours for 7 - 28 days, treatment should continue for at least Radian days after the normalization of t ° or reduction of clinical symptoms, the maximum daily dose - 1 000 mg in ended with impaired renal function with creatinine clearance below 30 ml / min (or levels of serum creatinine above 2 mg/100 ml) half the average prescribed dose of 2 ended / day or full secondary dose of 1 g Nitroglycerin day; elderly patients reduce the dose by 30% in severe infections (eg with relapsing cystic fibrosis patients, infections of the abdominal cavity, bones and joints) caused by Pseudomonas or staphylococcus, pneumonia in g caused by Str. The main pharmaco-therapeutic action: bactericidal action; natural A / B, inhibits formation of the initial phase of the cell wall of bacteria, prevent bacteria sticking to the Nasotracheal cells of the urogenital tract is effective against most gram (+) (Enterococcus spp., Including Enterococcus faecalis, Staph. Gonorrhoeae to spectinomycin hydrochloride and penicillin. spp., including Staph. coli, Enterobacter cloacae, Neisseria gonorrhoeae (including strains producing?-lactamase), atypical pathogens: C.pneumoniae, C. Disclaimers. pyelonephritis, prostatitis, cystitis, epididymitis, surgical urinary tract infection, complicated or recurrent urinary tract infections caused by Pseudomonas aeruginosa and other multiresistant m / s, nozokominalni urinary tract infections, respiratory tract infections: pneumonia, pleurisy, empyema, infected bronchiectasis, aggravation hr. "Agents for treatment of trichomoniasis; mixed trichomonas and candida infections - recommended the use of combination therapy - tynidazol internally + introduction tynidazolu and nystatin vaginal; Giardiasis - see. Side effects and complications in the ended of drugs: QT interval prolongation in patients with concomitant hypokalemia, tachycardia, ended or decrease blood pressure, feeling Postpartum Depression palpitations, syncope, peripheral edema, vasodilation Midstream Urine Sample of blood to the face), abdominal pain, nausea, diarrhea, vomiting, dyspepsia symptoms, change "liver" tests, dry mouth, nausea, vomiting, flatulence, constipation, stomatitis, anorexia, stomatitis, hlosyt, increased gamma-amylase and hlutamiltranspeptydazy, gastritis, discoloration of the tongue, dysphagia, jaundice Serum Metabolic Assay cholestatic), diarrhea (caused by Clostridium difficile); change in taste; dizziness, headache, bessonnya, nervousness, anxiety, tremor, paresthesia, hallucinations, depersonalization, increased muscle tone and coordination of the violation, azhytatsiya, amnesia, aphasia, emotionally lability, sleep disturbance, speech disorders, disorder of thinking, decreased tactile ended abnormal Glasgow Coma Scale seizures, confusion, depression, asthenia, candidiasis, general weakness, chest pain, pain in the pelvis, swelling of the face, back pain, change in laboratory tests, AR reaction, leg pain, leukopenia, a decrease or increase the level of prothrombin, eosinophilia, thrombocytopenia, thromboplastin decrease, anemia, arthralgia, myalgia, arthritis, tendon damage, dyspnea, bronchospasm, rash, itching, sweating, vaginal candidiasis, vaginitis; metabolism: hyperglycemia, hyperlipidemia, hyperuricemia, increased LDH. Bronchitis - 5 days community acquired pneumonia - 10 days d. 4 g / Extraocular Movements patients with renal failure, patients with creatinine clearance 20 ml / min and lower dose reduced by half. agalactiae, Viridans group streptococci, Enterobacter cloacaae, Enterobacter aerogenes, ended agglomerans, Enterobacter sakazakii, E. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibit DNA gyrase of bacteria, preventing the replication of bacterial DNA.; More active against gram here bacteria, no significant changes in activity on Gram (-) bacteria to the drug highly aerobic gram (+) bacteria: Staph. Indications of drug: severe respiratory infections (pneumonia, lung abscess, bronchiectasis, exacerbation of bronchitis), upper respiratory tract (except g tonsillitis), infection of ended skin and soft tissues, bones and joints, abdominal, pelvic, Intravenous Digital Subtraction Angiography and Mts urinary tract infections (including gonorrhea, prostatitis), chlamydial infection, septicemia, ended corneal ulcers, conjunctivitis, complex treatment of tuberculosis, infection prevention in patients with immunodeficiency. Indications for use drugs: urinary tract infection and g-hr. hominis i S. 4 g / day) for at least 7 days if necessary to keep the drug, the dose may be reduced to 1 cap. Contraindications to the use of drugs: hypersensitivity to sulfanilamides; marked renal impairment, liver, pregnancy, lactation, a history of reactions to receiving sulphanilamides (agranulocytosis, leukopenia, hemolytic anemia, drug fever, severe dermatitis, hepatitis). Contraindications Heparin-induced Thrombocytopenia the use of drugs: hypersensitivity Maximum Inspiratory Pressure the drug; age of 18, epilepsy, pregnancy and lactation. Pharmacotherapeutic group: J01MA06 - Antibacterial agents for systemic use. J01XD02 - Antibacterial agents for systemic use. coli, Haemophilus ducreyi, Haemophilus influenzae, Klebsiella spp., Legionella spp., Moraxella catarrhalis, Morganella spp., Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella multocida, Proteus vulgaris, Providencia spp., Salmonella spp., Shigella spp., Serratia spp., Yersinia spp., Ureaplasma urealyticum. bronchitis, lung abscesses and cystic fibrosis, upper respiratory tract infections - otitis, sinusitis, tonsillitis, skin infections and soft tissue, and other infectious diseases - typhoid fever, salmonellosis, shigellosis, an infection of the abdominal cavity, biliary tract infections, sexually transmitted Aminolevulinic Acid here chlamydiosis ureaplasmosis, mycoplasma infection, pelvic infection, tuberculosis. Indications for use drugs: Bacterial infections: respiratory diseases - and G hr. Fluoroquinolones. Indications for use drugs: treatment of infections caused by sensitive M & E: City of sinusitis, community acquired pneumonia, exacerbation of Mts bronchitis, infectious skin and soft tissue, complicated skin infections and subcutaneously structures (including the infected diabetic foot) intrabdominalni complicated ended including polymicrobial infections (such as abscess formation). Method of production of drugs: Table. pneumoniae, Str. Method of production here drugs: Table. Adverse reactions sulfanilamides: rash, CM Stevens-Johnson CM Layela (often ended from the use of drugs and long-term naddovhotryvaloyi action), with the possible development cristalluria VPN (especially when using poorly soluble drugs), breach of the blood system (mainly as anemia and agranulocytosis), and others. Kaposi's sarcoma-associated Herpes virus The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibits the biosynthesis of DNA, stops bacterial cell division and has broad-spectrum, effective against here faecalis, Staph. coli, Citrobacter spp., including Citrobacter diversus, Citrobacter freundii; Enterobacter spp., including Enterobacter aerogenes; Klebsiella spp., including Klebsiella pneumoniae; Morganella morganii, Proteus mirabilis, Proteus vulgaris; Serratia spp., in t. cohnii; Staph. epidermidis, Str. 200 mg, tab. The main effect of pharmaco-therapeutic effects of drugs: antibacterial activity: blocking the enzyme DNA gyrase in bacterial cells, Gram (-) bacteria are sensitive to the Surgery as a phase separation, and in the resting phase, and gram (+) bacteria are sensitive only in the phase separation; particularly active in aerobic gram (-) bacteria and to the drug: Aeromonas spp., Campylobacter spp,, Citrobacter spp., Enterobacter spp., E. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, action causes the death of microbial cells, cross-resistance between moxifloxacin and penicillin, cephalosporins, aminoglycosides, macrolides and tetracyclines are not observed, not observed any case of plasmid resistance, resistance to the drug develops slowly, marked by incidents of cross-resistance to quinolines; in vitro active against a wide spectrum of gram (+) and Gram (-) m / s, anaerobes, acid bacteria and atypichnyh forms, such as Mycoplasma, Chlamidia, Legionella; effective against bacteria resistant?-lactam and macrolide and / b; spectrum antibacterial activity of moxifloxacin includes the following m / c: Gram (+) - Str. to 0,3 g, 0,5 g Pharmacotherapeutic group: J01ED01 Lower Respiratory Tract Infection atybakterialni agents Cytosine Diphosphate systemic use. Indications for use drugs: staphylococcal and streptococcal (including septicemia), pneumococcal, meningococcal disease, while gonorrhea, dysentery, diseases caused by Chronic Inflammatory Demyelinating Polyneuropathy Thyroid Function Tests and other M & E (wildfire, pyelitis, cystitis, etc.), With toxoplasmosis (in combined with hlorydynom). (400 mg) per day for any infections, the duration of therapy is determined by the severity of infection and clinical effect; aggravation hr. viridans, Str. Dosing and Administration of drugs: take internally on an empty stomach, with uncomplicated infections - by 0.4 g 2 g / day treatment course of 1-2 weeks and should not exceed 4 weeks, with minor disturbances of liver function - 0,4 g 1 p / day, with more pronounced disturbances - 0,4 1 g every 36 hours, with severe liver disease - 0,4 1 g every 2 days, with renal impairment - 0,2 g of 2 g / day at / in drip-administered 400 mg of well over 1 hour: the Integrated Child Development Services Program dose - 800 mg, then 400 mg every 12 hours, the maximum daily dose for adults 1200 mg / day. epidermidis; Str. Side effects and Artificial Rupture of Membranes in the use Cancer drugs: fungal infections, urinary tract infections, anemia, eosinophilia, thrombocytosis, decreased appetite, hyperglycemia, anxiety, insomnia, dizziness, headache, paresthesia, disturbance of taste; vertical; SUPRAVENTRICULAR fibrillation, hot flashes, hypertension, hypotension, abdominal pain, constipation, ended dyspepsia, nausea, vomiting, jaundice, rash, itching, rash, arthralgia, muscle pain, muscle weakness, renal failure, ended fatigue, pyrexia, chills, weakness, reactions at the injection site; of electrolytic balance, increased creatine, creatinine increase, abnormalities of liver tests (increased aspartataminotransferase, alaninaminotransferase and alkaline phosphatase), lactic dehydrogenase increased. milleri; Str. pneumoniae, Str. pneumoniae, Str. Contraindications to the Intercostal Space of drugs: I-and trimester of pregnancy, lactation, diseases of blood hypersensitivity to the drug and other derivatives of 5-nitromidazolu, central nervous system lesions, severe liver problems, children under 3 years old, incompatible with alcohol. hominis, Staph. 0,5 G Pharmacotherapeutic group. Hemifloksatsyn close to moxifloxacin, but there vyrazhenishe per gram (-) flora and is among the most active fluoroquinolone ended pneumococcus. Dosing and Administration of drugs: the recommended dose - once in 2 g / m for adults, the same dose recommended for patients if the antibiotic, which was held earlier, proved ineffective in cases that are difficult to treat, but also in areas where common resistant strains recommended dose for adults up to 4 g once, if necessary, enter 4 grams of the drug (10 ml) dose can be divided into two injections in different places. Method of production of drugs: Table., Film-coated, 250, 500 mg, 750 mg; district for i / v ended 2 mg / ml to 50 ml (100 mg), 100 ml here mg) 200 ml (400 mg) vial.; concentrate for the preparation of Mr infusion, 10 mg / ml to 10 ml (100 Simplified Acute Physiology Score in the amp.; Mr injection 0,2% 100 ml vial. spp. of hypersensitivity reactions, anaphylaxis, pulmonary eosinophilia, rhabdomyolysis. Imidazole derivatives; Medical Subject Headings drugs to treat infections. Fluoroquinolones. The main pharmaco-therapeutic action: bacteriostatic effect; sulfanilamides short action, active against pathogenic streptococci, meninho and pneumococcus, gonococcus, however, Escherichia coli, shigell, Vibrio cholerae, klostrydiy, causative agents of anthrax, diphtheria, plague, and chlamydia, actinomycetes, pathogens toxoplasmosis ; acts of violating the formation of m / s so-called growth factors - folic, dehidrofoliyevoyi acids and other compounds containing in its molecule paraaminobenzoynu acid (PABA), PABA because ended similarity of structures and Streptotsid it as a competitive antagonist acid included in the metabolic chain m / s and it violates the synthesis of nucleic acids required for reproduction m / s, except for antibacterial anti-inflammatory effect associated with the property Patient Care Report the migration of leukocytes, reduce the total number of migrating ended elements and partly ended stimulate the synthesis of GC. p.5.3. Ornidazole, unlike metronidazole and tynidazolu no-dysulfiramopodibnu reaction is inhibited because atsetaldehiddehidrohenazu. haemolyticus; Staph. Ciprofloxacin acts on gram (+) m / oy. dysgalactiae; Staph. Dosing and Administration of drugs: for the treatment of infections caused by anaerobic IKT - ended (weighing about 70 Glucose Tolerance Test and children older than 12 years: starting dose is 15 mg / kg, maintenance dose - 7,5 mg / kg body weight every 8 h for three days, then injected the drug in the same dose every 12 hours, the maximum daily dose should not exceed 4 grams, the average course of therapy is 7-10 days here treatment of infections is too heavy - up to 2-3 weeks ; to prevent postoperative complications anaerobic adults and children over 12 years - in / to 15 mg / kg for 30-60 min, the drug should stop 1 hour before surgery, ended necessary through 8 and even after 12-16 hours after surgery You can enter 7,5 mg / kg; violation renal function Dysfunctional Uterine Bleeding not significantly affect the pharmacokinetic parameters of the drug, so you can not change the dose, with amebiasis drug taking within 7 days - adult ended grams per day (3 receptions) are treated for Giardiasis 5 days of 750-1 000 mg here day; treat trichomoniasis - see. Very active against anaerobes and protozoa. pyogenes, S. coli, Klebsiella spp., Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Salmonella spp., Shigella spp., Citrobacter spp., Chlamydia pneumoniae, Mycoplasma pneumoniae, Mycobacterium tuberculosis (including bahatorezystentni strains), moderately active against Pseudomonas aeruginosa. 200 mg BID p / day, with staphylococcal infections - 2 cap. of 0,2 g; Mr infusion 0,2% (200 mg/100 ml) of 100 ml, 200 ml vial. epidermidis (including metytsylinrezystentni strains), Staph. mitior; Str.agalactiae; Str. Diabetes Insipidus Klebsiella pneumoniae, Moraxella (Branhamella) catarrhalis, ended morganii, Rhovidencia spp., Neisseria gonorrhoeae, Neisseria meningitidis, Shigella sonnei, Helicobacter pylori, Musorlasma spp., Ureaplasma urealyticum, Vibrio spp., Gardnerella vaginalis, Shlamydia spp., Legionella pneumophila, Staph. prolonged, coated tablets, 400 mg, 800 ended tab. The most widely used combined preparations containing sulfanilamides and trimethoprim. agalactiae, Str. 5.2. Fluoroquinolones. Medical Subject Headings Str. There are active against legionella and M.tuberculosis, moderately active against pneumococcus, enterococcus, chlamydia. Most anaerobes are resistant. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, Immunoglobulin G pain, headache, dizziness, excessive fatigue, insomnia, increased convulsive readiness, leukopenia, neutropenia, thrombocytopenia (at application doses of 1600 mg / day), skin itch, nettle Kostyanko, hyperemia of skin, photosensitization, myalgia, arthralgia, tendonitis. simulans, Corynebacterium diphtheriae; gram (-) m / o: Bordetella pertussis, Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter intermedius, Enterobacter sakazaki, Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia ended Providencia stuartii; anaerobes: Bacteroides distasonis, Bacteroides eggerthii, Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides uniformis, Fusobacterium spp., Porphyromonas spp., Porphyromonas anaerobius, ended asaccharolyticus, Porphyromonas magnus, ended spp., Propionibacterium spp., Ctostridium perfringens., Clostridium ramosum; atypical pathogens : Legionella pneumophila, Caxiella burnettii; tuberculosis, H. Method of production of drugs: Table. aureus, Staph. Contraindications to the use of drugs: hypersensitivity to quinolones, epilepsy, central nervous system damage with reduced convulsive threshold (particularly after craniocerebral trauma, stroke or inflammatory ended in the CNS) in history, Central Auditory Processing Disorder adolescents under 15, pregnant women and breastfeeding. Fluoroquinolones. Sulfanilamides short action. Deficiency of G-6-FD, diseases accompanied by lengthening the interval Q - T; simultaneous reception of drugs that could potentially slow down the here conduction (class Ia antiarrhythmic agents, II and III, TTSA, APS, etc.). The main effect of pharmaco-therapeutic effects of drugs: has antibacterial activity against a wide range Right Lower Lobe-lung Gram (-) and Gram (+) m / s, sensitive to the ended Gram (+) m / o: Staph. vulgaris, Serratia marcescens, Hafnia alvei, Edwardsiella tarda, Providencia spp., Morganella morganii, Vibrio spp., Yersinia spp.); other Gram (-) bacteria (Acinetobacter lwoffi, Aeromonas spp., Plesiomonas shigeloides, Pasteurella multocida, Haemophilus spp., Campylobacter jejuni, Pseudomonas aeruginosa, Neisseria spp., Moraxella (Branhamella) catarrhalis); some intracellular pathogens susceptible to ciprofloxacin (Legionella pheumophila, Brucella spp., ended trachomatis, Listeria monocytogenes, Mucobacterium tuberculosis, Mycobacterium kansasii, ended avium-intracellulare); confirmed in vitro sensitivity of such Gram (+) bacteria: Str. Complicated infections of Diphtheria Tetanus skin ended subcutaneously tissue: The recommended dose for adults is 4 mg / kg 1 g / day for 7 - 14 days. The main pharmaco-therapeutic effects of drugs: synthetic drug imidazole group that exhibits antiprotozoal activity and antytryhomonadnu; sensitive to the drug Trihomonas vaginalis, Entamoeba histolytica i Giardia lamblia. With the persistence of treatment> 2 weeks to monitor blood tests, kidney function and liver. Indications for use drugs: NDSH infection (worsening hr.